Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

Tetraphase hires Patheon to make its synthetic antibiotic eravacycline

Tetraphase Pharmaceutical has hired Patheon UK Limited to make and test the synthetic antibiotic eravacycline.


US FDA slams Chinese API maker over data breaches

Qinhuangdao Zizhu omitted, deleted and manipulated manufacturing data at its active pharmaceutical ingredient plant in Hebei, China according to the US FDA.

Germany’s Merck invests in immune-oncology in Switzerland

Merck KGaA’s corporate venture division has created an immune-oncology company based on a mixture of small and large molecule drugs, including Merck and Pfizer’s Bavencio (avelumab). 

Implementing continuous manufacturing a challenge, say industry delegates

Industry professionals at a continuous manufacturing (CM) summit last month said while the approach offers advantages, implementing the method can be challenging.

US bans drugs and all but one API made at three IPCA Labs plants

The US FDA has banned all drugs and all but one of the APIs made by Ipca Laboratories at its facilities in Ratlam, Indore and Piparia.

Corning life science focus: '21st century glass for 21st century drugs'

Corning says it is on the brink of capturing an increased share of the $12bn glass quality and packaging markets through material advancements in the space.

EMA, FDA and PMDA aim to give antibiotic firms option of global trial programme

The EMA says aligning antibiotic trial requirements with the US FDA and Japan’s PMDA should allow drug firms to conduct single global development programmes.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...